Intercept Pharma's (ICPT) OCA Receives Breakthrough Therapy Designation in NASH
Tweet Send to a Friend
Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) (Intercept), today announced that its investigational product obeticholic acid (OCA) has received "breakthrough therapy designation ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE